To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: Neutrophil Extracellular Traps (NETs) have been associated with various aspects of tumor progression, such as primary growth, aggressiveness, and metastasis. Our group has recently demonstrated that NETs promote a pro-metastatic phenotype in nonaggressive breast cancer cell lines through the epithelial-mesenchymal transition (EMT) process. This has been linked to resistance to chemotherapeutic agents, but little has been reported regarding the role of NETs in driving these events. Thus, this study aims to analyze NETs’ ability to modulate an antiapoptotic phenotype in human breast cancer cells. MATERIAL AND METHODS: We used three breast cancer cell lines in this study: MCF7 and T47D (described as epithelial, less aggressive and sensitive to chemotherapeutic agents) and MDA-MB231 (described as undifferentiated, highly aggressive and resistant to chemotherapeutic agents). Neutrophils separated from the blood of healthy donors were stimulated with Phorbol 12-myristate 13-acetate PMA to produce NETs which were further isolated using an established protocol. The cell lines were treated with isolated NETs for 24 or 48 h. In some cases, prior to the treatment with NETs, cells were treated for 1h with either PI3K (LY294002), AKT (MK-2206) or NF-kB (BAY117085) inhibitors. Samples were collected for real-time PCR and Western Blot, and the expression of Bcl-2 and Bax was analyzed. A clonogenic assay, MTT assay and Western Blot for effector components of the apoptotic pathway were performed to evaluate the functional impacts of NETs on cellular response to doxorubicin. RESULTS AND CONCLUSION: In vitro analysis showed that NETs were not cytotoxic for none of the cell lines. NETs treatment upregulated the mRNA expression of Bcl-2, an antiapoptotic protein, in all cell lines, while downregulating the expression of Bax, a proapoptotic protein. Colony formation was improved in cells treated with NETs as compared to untreated cells. Notably, NETs were able to protect cells against doxorubicin treatment. Treatment with PI3K, AKT and NF-kB inhibitors prevented the protective effects of NETs towards doxorubicin, as evidenced by MTT assay. In sum, we conclude that exposure of breast cancer cell lines to NETs confer a chemoresistant phenotype, functionally impacting responses to doxorubicin, via PI3K/AKT/NF-kB pathway. KEYWORDS: Breast cancer, neutrophil extracellular traps (NETs), apoptosis, chemoresistance. SUPPORTED BY: CAPES, CNPq, Fundação do Câncer and FAPERJ.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper